Journal
DISEASE MODELS & MECHANISMS
Volume 14, Issue 9, Pages -Publisher
COMPANY BIOLOGISTS LTD
DOI: 10.1242/dmm.049078
Keywords
CRISPR; Cancer; Chromosomal rearrangements; Fusion oncogenes
Categories
Funding
- Memorial Sloan Kettering [T32-CA009512]
Ask authors/readers for more resources
The advancements and innovations in technology have made it easier and more accurate to model cancer-associated chromosomal rearrangements in the laboratory, aiding in a better understanding of the mechanisms that regulate cancer growth.
The identification of large chromosomal rearrangements in cancers has multiplied exponentially over the last decade. These complex and often rare genomic events have traditionally been challenging to study, in part owing to lack of tools that efficiently engineer disease-associated inversions, deletions and translocations in model systems. The emergence and refinement of genome editing technologies, such as CRISPR, have significantly expanded our ability to generate and interrogate chromosomal aberrations to better understand the networks that govern cancer growth. Here we review how existing technologies are employed to faithfully model cancer-associated chromosome rearrangements in the laboratory, with the ultimate goal of developing more accurate pre-clinical models of and therapeutic strategies for cancers driven by these genomic events.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available